Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03551028 · ClinicalTrials.gov registry record · NA
HPV DNA Testing Through Mobile Mammography Unit
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT03551028 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 33 participants.
The verdict
NCT03551028, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Invasive cervical cancer incidence and mortality can be dramatically reduced through early detection and treatment, but many women do not complete screening at recommended intervals. Many low-income women in Virginia remain uninsured and are at significant risk of being medically underserved and failing to complete regular cervical cancer screening. Self-collection of specimens for HPV testing is an innovative approach that may increase access to cervical cancer screening in populations that do not participate in traditional clinic-based screening. Innovative delivery models are needed to reach at-risk populations. This study seeks to explore the acceptability and feasibility of pairing self-collection of HPV samples for DNA testing with mobile mammography in women living in rural Virginia.
Interventions
- DEVICE HPV self collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2016-07 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03551028
The ClinicalTrials.gov registry entry for NCT03551028 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HPV self collection is the first listed.
NCT03551028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03551028 about?
NCT03551028 is a clinical study titled "HPV DNA Testing Through Mobile Mammography Unit". Invasive cervical cancer incidence and mortality can be dramatically reduced through early detection and treatment, but many women do not complete screening at recommended intervals. Many low-income women in Virginia remain uninsured and are at significant risk of being medically underserved and fai...
What is the current status of trial NCT03551028?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2016-07. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT03551028?
The interventions under investigation include: HPV self collection (DEVICE).
Who is sponsoring clinical trial NCT03551028?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.